Vincent Groot

@clintoptions $SPY

As you all know, I’m officially restarting the $500 to $1 Million 2026 Challenge this week 🚀 I’m opening a FREE private X group where you’ll see my exact entries & exits live. To be added: Like + Comment “$SPY” (You must be following!)

🚨 Check out our newest study on how recurrence treatment of #PancreaticCancer is influenced by prior treatment

@sciqst @AnnalsofSurgery @DPCG_official @MarcBesselink @Gio_Marchegiani @IqQ4q @HpbRaku @YouppiePancreas This was a retrospective study, there was no selection of patients for imaging vs routine follow-up (doctor and patient preference). We are conducting the RADAR-panc trial to answer most of these questions, expecting results next year! trialsjournal.biomedcentral.com/articles/10.11…

Interesting findings! Routine imaging potentially catches asymptomatic recurrences earlier, opening avenues for timely interventions. I'm curious about the study's selection criteria for routine imaging and how it weighs against costs and patient stress. Any thoughts on its applicability in different healthcare settings? For comprehensive insights on biomedical questions and review generation, check out [sciqst.com](sciqst.com), a one-stop platform making knowledge accessible for all. #Medicine #CancerResearch

🚨 New in @AnnalsofSurgery showing ⬆️ survival with routine imaging vs symptomatic follow-up after #pdac resection. 🕵🏼‍♂️Routine imaging also associated with asymptomatic recurrence and recurrence treatment. @DPCG_official @MarcBesselink @Gio_Marchegiani journals.lww.com/annalsofsurger…

@YouppiePancreas @lelecapurso @German_PancClub @EurPancClub @Lguilabert1 @SN_gastro Congrats Mat!

Congratulations to our YOUPPIE awardees this year🥇🎉🍾🎊 Sandra Heller and Matthäus Felsenstein‼️ Come to the #EPC2025 to listen to their talks, July 3️⃣rd at 17:45 in Dusseldorf 🇩🇪

@MarcBesselink @AmerSurg @IHPBA @EAHPBA @AHPBA @HopkinsMedicine @AndrewMCameron @jhatjhmi1 @P_C_E_ @DPCG_official Living Legend!

Professor John Cameron, living legend 👑 and one of the first Trialists in #pancreatic #surgery: 88 years but alive and kickin’ at @AmerSurg in San Diego🇺🇸 A true leader by example and inspiration for all of us!! @IHPBA @EAHPBA @AHPBA @HopkinsMedicine

Lung only metastatic PDAC 🫁 Better survival than liver! In @NatureCancer 🧬 a primary organotropism (pORG) gene set analysis 👮 Lung-avid/liver-averse tumors associated with active tumor immunity / less replication stress 😥 🤌 Your policy!? nature.com/articles/s4301…

@Gio_Marchegiani @EAHPBA @MarcBesselink @JAMASurgery @Serrablohpb @sparrelid @BasGrootKoerkam @iisifrigerio @Simone_Aug @IHPBA @hpb_trials @hpb_so Thanks voor promoting our study @Gio_Marchegiani!

(Let’s keep using this social in the best possible way … ) 🫢 🟠 Recurrence after PDAC resection is sadly a fact 🔵 @EAHPBA study on 333 pts reveals routine imaging in post op 👍 vs. symptomatic FU 💡Prompt access chemo = better survival jamanetwork.com/journals/jamas…

🎓 Check out our latest paper in @JAMASurgery! @YouppiePancreas @hpb_so @HpbRaku

🎓 Check out our latest work in @JAMASurgery on postoperative follow-up strategies after surgery for #pancreaticcancer. In this first prospective international study on this topic, results show that routine post-operative imaging can be beneficial. pubmed.ncbi.nlm.nih.gov/39504033/

🎓 Protocol of RADAR-PANC has been published! This RCT will be the first to generate high level evidence on the value of recurrence-focused postoperative surveillance in patients after pancreatic cancer resection. @LoisDaamen @hpb_so @YouppiePancreas trialsjournal.biomedcentral.com/articles/10.11…

@timpawlik @OhioStateSurg @AlexBlairMD @MSKCancerCenter @hopkinssurgery @OSUCCC_James @OSUWexMed @OhioStateNews @OhioStateMed @SocSurgOnc @AHPBA @isteaus @mary_dillhoff @jcloydmd Well deserved @AlexBlairMD! Go rock their world 💪

Alex Blair, MD is joining @OhioStateSurg Div Surg Onc!! @AlexBlairMD is currently completing #HPB & #CSGO fellowships @MSKCancerCenter after residency @hopkinssurgery. His research focuses on targeted modulation of tumor microenvironment to enhance #pancreatic #cancer treatment.

To highlight our special issue, we (@LoisDaamen & @IqQ4q) wrote an editorial named: Recent Advances and Future Challenges in Pancreatic Cancer Care: Early Detection, Liquid Biopsies, Precision Medicine and Artificial Intelligence. Want to read more? Link: mdpi.com/2077-0383/12/2…

🏥Substantial new contribution by friends and former @HopkinsMedicine colleagues @BradReames & @AEjaz85 to our special issue in the @JCM_MDPI. 🎓Read their systematic review on recurrence patterns after resection of IPMN through this link: mdpi.com/2077-0383/13/3…. @LoisDaamen

🎓 Thank you @FelixAberer for a new and important contribution to our special issue in the @JCM_MDPI, elucidating the impact of diabetes mellitus on the outcomes of patients undergoing pancreatic surgery. Article link: mdpi.com/2077-0383/12/2… @LoisDaamen & @IqQ4q

🚨 Happy to share the first contribution to our special issue "Pancreatic Cancer: Recent Advances and Future Challenges" in the @JCM_MDPI. Article link: mdpi.com/2077-0383/12/1…. Contribute your own pancreatic research through: mdpi.com/journal/jcm/sp…. @LoisDaamen & @IqQ4q

🚨Check out below our highlighted article by @ejsotweets on predicting post-recurrence survival after #pancreaticcancer resection. @LoisDaamen @hpb_so @YouppiePancreas @jhatjhmi1

⬇️⬇️Submit your pancreatic research! ⬇️⬇️

We cordially invite you to submit your original or review article on clinical or translational research to this Special Issue through the following link: mdpi.com/journal/jcm/sp…. @YouppiePancreas @hpb_so

Dear colleagues, As Guest Editors (together with @LoisDaamen & @IqQ4q), we are pleased to announce the launch of a new Special Issue entitled: “Pancreatic Cancer: Recent Advances and Future Challenges” to be published in the Journal of Clinical Medicine (@JCM_MDPI, IF 3.9).